acarbose vs insulin detemir
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of acarbose and insulin detemir. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Precose
Levemir
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes. It works best when used with diet and exercise.
Levemir is a long-acting insulin that helps control blood sugar levels in people with diabetes. It works slowly over about 24 hours to keep your blood sugar stable.
Acarbose is used to help control blood sugar in adults with type 2 diabetes. You should use it along with a healthy diet and regular exercise. This medicine helps to keep your blood sugar from getting too high after you eat.
Levemir is used to improve blood sugar control in adults and children with diabetes. It helps manage high blood sugar levels. However, it is not used to treat diabetic ketoacidosis, a serious condition with very high blood sugar and ketones.
Acarbose slows down the digestion of carbohydrates (sugars and starches) in your body. It does this by blocking certain enzymes in your small intestine that break down carbs. This helps to prevent a sharp rise in blood sugar after meals.
Levemir is a long-acting form of insulin. It works by helping your body use sugar from the blood for energy. This lowers your blood sugar levels and keeps them more stable over time.
- • Gas
- • Diarrhea
- • Abdominal pain
- • Upper respiratory infection
- • Headache
- • Sore throat
- • Flu-like illness
- • Abdominal pain
- Hypoglycaemia 269
- Nausea 203
- Blood Glucose Increased 200
- Dizziness 160
- Diarrhoea 147
- Blood Glucose Increased 6,220
- Nausea 1,972
- Blood Glucose Decreased 1,568
- Fatigue 1,534
- Diarrhoea 1,399
You should not take acarbose if you have diabetic ketoacidosis or cirrhosis. Also, do not take it if you have inflammatory bowel disease, colon ulcers, or any bowel obstruction. This medicine can cause liver problems in some people. Tell your doctor right away if you develop symptoms like yellowing of the skin or eyes.
Never share your Levemir FlexPen, needle, or insulin syringe with anyone else, even if you change the needle. Sharing these items can spread blood-borne diseases. Changes in your insulin regimen can cause high or low blood sugar. Always check the insulin label before injecting to avoid medication errors. Low potassium can occur, monitor potassium levels. Heart failure can occur when taking Levemir with thiazolidinediones (TZDs).
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acarbose will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if acarbose passes into breast milk.
Tell your doctor if you are pregnant or plan to become pregnant. Good control of diabetes is important during pregnancy for both you and your baby. Levemir can be used during pregnancy.
Also Compare, Nearby Drugs
Compare acarbose with
Compare insulin detemir with
How to Read This acarbose vs insulin detemir Comparison
acarbose is classified in the Alpha-Glucosidase Inhibitor drug class, while insulin detemir sits within the Long-Acting Insulin class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acarbose has 979 submissions while insulin detemir has 12,693. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for acarbose or insulin detemir.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.